Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from diabetes

Sub-six hours sleep may raise type 2 diabetes risk - Tech & Science Daily Podcast

All the stories from Wednesday’s episode of the Tech & Science Daily podcast.

Evening Standard

Lance Bass Embraces Healthy Lifestyle Amid Diabetes Diagnosis And Allergies

Lance Bass Embraces Healthy Lifestyle Amid Diabetes Diagnosis And Allergies

Lance Bass opens up about managing diabetes, exercise, mental well-being, and partnering with Allegra for allergy management.

Newcastle uni's needle-free diabetes test wins Shaping Australia Award

Newcastle uni's needle-free diabetes test wins Shaping Australia Award

The biosensor is 100 times more sensitive than other blood sensors.

Newcastle Herald

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Less Than 5 Hours Of Daily Sleep Raises Diabetes Risk Despite Healthy Eating: Study

The diabetes risk from chronic sleep deprivation cannot be compensated by healthy eating alone, the study revealed.

Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News

DaVita stock launched Tuesday after Novo Nordisk unveiled the results of its weight-loss drug in kidney disease patients.

Investors Business Daily

‘Life is meaningless’: despair in Cox’s Bazar as chronic illness blights camps

Rohingya people who fled genocide in Myanmar for the refugee camps in Bangladesh, are finding their lives devastated by diseases such as cancer and diabetes

The Guardian - UK

Ultra-Processed Food Linked To 32 Health Issues: Early Death, Heart Disease, And Cancer

Ultra-processed food has a connection to 32 health issues, including diabetes, heart disease, poor mental health, cancer, and premature death.

inkl

Read news from The Economist, FT, and more,
with one subscription

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.

Drug-Free Treatment For Diabetes? Study Says Red Light Therapy Could Reduce Blood Sugar Levels

Drug-Free Treatment For Diabetes? Study Says Red Light Therapy Could Reduce Blood Sugar Levels

A study has uncovered a potential drug-free treatment for diabetes, as researchers noted a significant reduction in blood sugar levels after a single session of a 15-minute red light therapy.

CMC to organise competitions to commemorate World Diabetes Day

CMC to organise competitions to commemorate World Diabetes Day

Vellore CMC hosts dance competition with 'Kidney and Diabetes' theme to raise awareness and promote kidney health.

FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

FDA warns consumers about potential health risks of using smartwatches for blood glucose monitoring. Stay informed for accurate diabetes management.

How harmful are seed oils?

How harmful are seed oils?

"They may or may not play a role in inflammation (the research picture is mixed)"

Millions In England At Risk Of Undiagnosed Type 2 Diabetes

Millions In England At Risk Of Undiagnosed Type 2 Diabetes

Report highlights 1 million undiagnosed Type 2 diabetes cases in England, stressing early detection and management to prevent complications.

Third of Londoners living with type 2 diabetes are undiagnosed, figures show

Millions more are at risk of developing the condition

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

“They Can’t Afford It”: Kelly Osbourne Slammed For “Classist” Ozempic Comment

After her mother shared her negative experience with Ozempic, Kelly Osbourne praised the drug as "amazing" during a new interview. The post “They Can’t Afford It”: Kelly Osbourne Slammed For “Classist” Ozempic Comment first appeared on Bored Panda.

The Guardian - UK

Patients with chronic illnesses in Gaza failing to get treatment, doctors warn

The lack of medicine, food and water means thousands of people with asthma, kidney disease or diabetes are unable to treat or control their conditions

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Investors Business Daily

Will Weight-Loss, Diabetes Drugs Drive LLY Stock Into $1 Trillion Club?

Eli Lilly's weight-loss and diabetes drugs Zepbound and Mounjaro should drive the biopharma stock much higher, said a Morgan Stanley analyst.

Get all your
news in one place.

100’s of premium titles.
One news app.

Mouthwash Use May Improve Blood Sugar Levels In Some Diabetic Patients: Study

Researchers believe that if patients who are likely to respond well to antiseptic mouthwash could be identified, it would be an easy-to-use treatment for people with periodontic-linked diseases.

Health: Pregnancy complications can also affect child's health later in life

Two of the most frequent pregnancy-problems">pregnancy problems are hypertensive disorders of pregnancy (HDP) and gestational diabetes (GDM), which increase pregnant people's risk of developing cardiovascular disease later in life. Read further on Dynamite News:

FDA Warns Online Vendors Selling Misbranded Weight-Loss and Diabetes Drugs

The FDA issues warnings to online vendors selling misbranded weight-loss and diabetes drugs, highlighting potential health risks and illegal practices.

The Guardian - UK

Weight-loss drugs need to become cheaper, says AstraZeneca boss

Loss of muscle mass also flagged, as UK drugmaker works with China’s Eccogene on obesity and type 2 diabetes pill

How many Americans have diabetes?

The prevalence of diabetes increased from 10.3% of people in 2001 to 11.6% in 2021.

Eli Lilly & Co. (LLY) Pre-Earnings Moves: Buy or Watch?

Eli Lilly (LLY) saw steady growth in its last reported quarter, driven by sales from its popular diabetes drug Mounjaro. The stock has had an impressive run over the past year. However, will the momentum be sustained following its upcoming earnings release scheduled for tomorrow? Read on.

Kidney stone risk is lowered by a class of diabetes medications

Type 2 diabetes is related to an increased risk of kidney stones; however, various forms of treatment for this condition may potentially reduce the risk of kidney stones. Read further on Dynamite News:

1 … 14 15 16 17

People

Sharon Osbourne

Chelsea Handler

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Office for National Statistics

University of Newcastle

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Gestational Diabetes

Places

238,368 stories

100,645 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play